Cargando…

Inflammatory Markers in Women with Polycystic Ovary Syndrome

Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation to be of uncertain cause: obesity, insulin resistance, or PCOS itself. The aim of the study was to investigate the WBC (white blood cell) count and CRP (C-reactive protein) conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M., Smolarczyk, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079227/
https://www.ncbi.nlm.nih.gov/pubmed/32219132
http://dx.doi.org/10.1155/2020/4092470
_version_ 1783507785470705664
author Rudnicka, E.
Kunicki, M.
Suchta, K.
Machura, P.
Grymowicz, M.
Smolarczyk, R.
author_facet Rudnicka, E.
Kunicki, M.
Suchta, K.
Machura, P.
Grymowicz, M.
Smolarczyk, R.
author_sort Rudnicka, E.
collection PubMed
description Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation to be of uncertain cause: obesity, insulin resistance, or PCOS itself. The aim of the study was to investigate the WBC (white blood cell) count and CRP (C-reactive protein) concentration in women with PCOS and to determine the factors that affect their concentration. The study included 200 women aged 18-40 with PCOS and 105 healthy women as the control group, recruited in the Department of Gynaecological Endocrinology of Medical University in Warsaw from 2016 to 2018. Each patient underwent clinical, biochemical, and ultrasonographic assessments. WBC and CRP were significantly higher in the PCOS group (Z = −2,353, p = 0,019 and Z = −2,453, p = 0,014). WBC positively correlated with serum insulin at 0, 60, and 120 min during the oral glucose tolerance test (INS0: r = 0,221, p = 0,001; INS1: r = 0,194, p = 0,003; INS2: r = 0,022, p = 0,001), testosterone (r = 0,130, p = 0,046), androstenedione (r = 0,212, p = 0,001), and DHEAS (r = 0,178, p = 0,006) and negatively correlated with progesterone (r = −0,204, p = 0,002), estradiol (r = −0,140, p = 0,032), and SHBG (r = −0,308, p < 0,001). CRP positively correlated with insulin concentration in 0, 60, and 120 min during the oral glucose tolerance test (INS0: r = 0,343, p < 0,001; INS1: r = 0,276, p = 0,001; INS2: r = 0,320, p < 001) and negatively correlated with progesterone (r = −0,194, p = 0,030) and SHBG (-0,244, p = 0,005). We also estimated positive correlation between BMI and serum CRP and WBC concentration. Multiple linear regression analysis showed that CRP values are positively associated with BMI (beta = 0,374, p < 0,001) and insulin level (INS1) (beta = 0,282, p = 0,004); and WBC results are negatively associated with SHGB (beta = −0,284, p < 0,001) but positively associated with testosterone (beta = 0,163, p = 0,024) and BMI (beta = 0,157, p = 0,047). PCOS is associated with increased WBC and CRP concentrations. The main predicting factors of increased CRP are BMI and insulin resistance, but there is also a relationship between WBC count in PCOS and androgen concentration itself so that inflammation may be mediated not only through adiposity but also through increased androgen concentration.
format Online
Article
Text
id pubmed-7079227
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70792272020-03-26 Inflammatory Markers in Women with Polycystic Ovary Syndrome Rudnicka, E. Kunicki, M. Suchta, K. Machura, P. Grymowicz, M. Smolarczyk, R. Biomed Res Int Research Article Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation to be of uncertain cause: obesity, insulin resistance, or PCOS itself. The aim of the study was to investigate the WBC (white blood cell) count and CRP (C-reactive protein) concentration in women with PCOS and to determine the factors that affect their concentration. The study included 200 women aged 18-40 with PCOS and 105 healthy women as the control group, recruited in the Department of Gynaecological Endocrinology of Medical University in Warsaw from 2016 to 2018. Each patient underwent clinical, biochemical, and ultrasonographic assessments. WBC and CRP were significantly higher in the PCOS group (Z = −2,353, p = 0,019 and Z = −2,453, p = 0,014). WBC positively correlated with serum insulin at 0, 60, and 120 min during the oral glucose tolerance test (INS0: r = 0,221, p = 0,001; INS1: r = 0,194, p = 0,003; INS2: r = 0,022, p = 0,001), testosterone (r = 0,130, p = 0,046), androstenedione (r = 0,212, p = 0,001), and DHEAS (r = 0,178, p = 0,006) and negatively correlated with progesterone (r = −0,204, p = 0,002), estradiol (r = −0,140, p = 0,032), and SHBG (r = −0,308, p < 0,001). CRP positively correlated with insulin concentration in 0, 60, and 120 min during the oral glucose tolerance test (INS0: r = 0,343, p < 0,001; INS1: r = 0,276, p = 0,001; INS2: r = 0,320, p < 001) and negatively correlated with progesterone (r = −0,194, p = 0,030) and SHBG (-0,244, p = 0,005). We also estimated positive correlation between BMI and serum CRP and WBC concentration. Multiple linear regression analysis showed that CRP values are positively associated with BMI (beta = 0,374, p < 0,001) and insulin level (INS1) (beta = 0,282, p = 0,004); and WBC results are negatively associated with SHGB (beta = −0,284, p < 0,001) but positively associated with testosterone (beta = 0,163, p = 0,024) and BMI (beta = 0,157, p = 0,047). PCOS is associated with increased WBC and CRP concentrations. The main predicting factors of increased CRP are BMI and insulin resistance, but there is also a relationship between WBC count in PCOS and androgen concentration itself so that inflammation may be mediated not only through adiposity but also through increased androgen concentration. Hindawi 2020-03-04 /pmc/articles/PMC7079227/ /pubmed/32219132 http://dx.doi.org/10.1155/2020/4092470 Text en Copyright © 2020 E. Rudnicka et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rudnicka, E.
Kunicki, M.
Suchta, K.
Machura, P.
Grymowicz, M.
Smolarczyk, R.
Inflammatory Markers in Women with Polycystic Ovary Syndrome
title Inflammatory Markers in Women with Polycystic Ovary Syndrome
title_full Inflammatory Markers in Women with Polycystic Ovary Syndrome
title_fullStr Inflammatory Markers in Women with Polycystic Ovary Syndrome
title_full_unstemmed Inflammatory Markers in Women with Polycystic Ovary Syndrome
title_short Inflammatory Markers in Women with Polycystic Ovary Syndrome
title_sort inflammatory markers in women with polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079227/
https://www.ncbi.nlm.nih.gov/pubmed/32219132
http://dx.doi.org/10.1155/2020/4092470
work_keys_str_mv AT rudnickae inflammatorymarkersinwomenwithpolycysticovarysyndrome
AT kunickim inflammatorymarkersinwomenwithpolycysticovarysyndrome
AT suchtak inflammatorymarkersinwomenwithpolycysticovarysyndrome
AT machurap inflammatorymarkersinwomenwithpolycysticovarysyndrome
AT grymowiczm inflammatorymarkersinwomenwithpolycysticovarysyndrome
AT smolarczykr inflammatorymarkersinwomenwithpolycysticovarysyndrome